Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

PSNC: scrapping the NMS would be a mistake

Services Cutting the NMS would be detrimental to the government’s drive to improve medicines adherence, PSNC has said, as pharmacists warned the service could be an easy target for NHS cuts.

Scrapping the new medicine service (NMS) would be detrimental to the government's drive to improve medicines adherence, PSNC has said, as pharmacists warned the service could be an easy target for NHS cuts.

PSNC expected the Department of Health (DH) to recommission the NMS next year, after figures released last week showed the service was helping patients take their medicines properly, contractor and chair of the PSNC service development subcommittee Gary Warner said.

The figures, collected through PSNC's PharmOutcomes, covered NMS interventions to more than 224,000 patients from the service's launch on October 1, 2011 to September 30, 2012. It revealed that 32 per cent of non-adherent patients became more adherent to their medication following NMS interventions.

"To withdraw it might be detrimental to the work that we're doing with the DH in terms of improving adherence and reducing waste" Gary Warner, PSNC

More on the NMS

NMS works for patients, it must work for you too

NMS improves medicines adherence, PSNC finds

Jonathan Mason on improving NMS interventions

Mr Warner said the final decision on the NMS's future would be confirmed following the evaluation by Nottingham University research group to be published next year, but he hoped the latest figures showed the service was "not only valuable but invaluable".

"To withdraw it might be detrimental to the work that we're doing with the DH in terms of improving adherence and reducing waste," Mr Warner said.

But community pharmacist Clive Hodgson said he could see "certain people in the DH seeing [the decommissioning of NMS] as an attractive option".

"It's all down to funding. Let's put it this way, if NMS was cancelled tomorrow due to the money saved, I think you've got to ask yourself: how much would patients lose? I think only a bit," he said.

And community pharmacist Hassan Argomandkhah told C+D the NMS was "designed to fail from the beginning".

"The DH wanted to take money out of pharmacy and didn't want to put it back in properly," Mr Argomandkhah said. "I don't think the service as it's designed is supporting patients because there is a lot of duplication."

However, Mr Warner praised contractors, whose engagement with the NMS he called "phenomenal".

"They've engaged with it, they've delivered it, and I think what's really key for me is talking to pharmacists that are delivering it, [you get] a really positive sense that they're doing something positive for patients."


Do you think the NMS should survive DH funding cuts?

Comment below or email us at [email protected] You can also find C+D on Twitter, LinkedIn and Facebook

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD015869

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel